company profile* shareholders:barut and esirtgen families abdi ibrahim tower: istanbul, turkey ...
TRANSCRIPT
Company Profile* Shareholders: Barut and Esirtgen Families
Abdi Ibrahim Tower: Istanbul, Turkey
Production and R&D: Esenyurt, Istanbul
Turnover: $853 million
Export: $27 million
Production Capacity: 350 million boxes
Product Range: 53% original pharmaceuticals47% generic pharmaceuticals
Licensors: ~ 30 international companies
Employees: ~ 3,300To
da
y’s
Ab
di
Ibra
him
www.abdiibrahim.com.tr
About the Company
* As of December 2011
Vision
To be a well-respected, widely preferred
global player that strives to grow more
rapidly than the respective
pharmaceutical market
www.abdiibrahim.com.tr
About the Company
Mission
To produce and supply healthcare products
through a pioneering and innovative
approach, for the benefit of medicine and
humanity
A Journey of 100 Years to the Summit
1999 - 20121941 - 19991912 - 1940
The business started in 1912 with a small pharmacy in Istanbul
In 1940, the number of drugs produced at the Abdi Ibrahim Laboratory reached 80
The foundations of the production facilities were laid in 1994
In 1999, international expansion started with the first venture into Algeria
Portfolio: 150 brands, more than 250 products, close to 30 licensors, exports to more than 20 countries
EU GMP approved manufacturing facility and first accredited R&D
www.abdiibrahim.com.tr
About the Company
Istanbul
Istanbul
Algeria
Industry Leader for 9 Years
www.abdiibrahim.com.tr* As of December 2011
Turnover — Consolidated Turnover (Millon $)
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
186 160
217
335
400
575 614
805 849
761
896 853
Turnover — Consolidated Turnover (TL)
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
110
201
329
495 577
774
878
1,035
1,158 1,160
1,343 1,424
Domestic Sales Development
www.abdiibrahim.com.tr
Industry Leader
* As of December 2011
Turnover Development (TL) Turnover Development ($ mio)
Domestic sales (contract man. included) Domestic sales turnover (contract man. included)
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
185 157
212
327
387
559 603
786 819
735
865 826
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
110 197
322
484 560
753
861
1,011
1,114 1,121
1,297 1,379
Market Share Leader in TurkeyMarket Share — Units (2011) Market Share — $ Turnover (2011)
www.abdiibrahim.com.tr
Industry Leader
Ref. IMS
ABDI
Bayer
Bilim
Eastpharma
Ulugay
Sanofi
Novartis
Glaxo-SmithKline
Pfizer
Santa Farma
9.3%
6.8%
6.2%
5.6%
4.9%
4.7%
3.8%
3.4%
3.3%
3.2%
ABDI
Novartis
Bilim
Pfizer
Eastpharma
Glaxo-SmithKline
Sanofi
Bayer
Astra Zeneca
Sanovel
7.9%
6.0%
5.1%
4.8%
4.1%
3.8%
3.7%
3.4%
3.3%
2.9%
Export Development
www.abdiibrahim.com.tr
Industry Leader
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
1
3 5
8
13
16
11
19
30
25
31
27
US $ million
$274 Million Investment (1990-2011)
Fixed Assets $ million www.abdiibrahim.com.tr
Industry Leader
48.4
225.2
Before 2000
After 2000
Success is a Team GameThe Largest Sales and Marketing Team in Turkey (2010 - 2011)
www.abdiibrahim.com.tr
Industry Leader
* Includes Abdica, Reformed and International Markets
R&D
İbdi
İbra
him
Tow
er
Fact
ory
Fiel
d
150
400550
2100
Number of employees
~ 3300*
Manufacturing Plant
Production Capacity: 350 million boxes
Production Area: 25,000 sqm Employees: > 500
• Adhering to global standards• cGMP and cGLP certifications• ISO 14001 Environmental Management
System Certification• OHSAS 18001 Work Safety Certification• EU GMP approved facility• “Energy-Efficient Industrial Facility” Award
in 2007• Modern, efficient and environment-
friendly technology• 2D Matrix Codes technology in the
production line automation system
Logistic Center
Closed Area: 22,000 sq m
Total Palette Capacity: 14,500
• With an investment of $35 million,
Abdi Ibrahim Logistic Center is
equipped with the latest state-of-
the-art equipment allowing for faster
transport and greater performance
with fully automation system
First Accredited R&D Center in Turkey
Total Closed Area: 13,600 sq mLaboratory: 2,000 sq mPilot Production Area: 900 sq mOffices: 450 sq mStorage Area: 350 sq mEmployees: > 150
High level of success in bioequivalence studies
CTD files for Turkey and Europe Accelerated development process for
equivalent products Development of value-added products
Abdi Ibrahim Global
www.abdiibrahim.com.tr
Export to more than 20 Countries
Production of Original and Generic Pharmaceuticals
Licensing
Marketing and Registration
Global Reach
Licencors
www.abdiibrahim.com.tr
Global
www.abdiibrahim.com.tr
List of Countries AİOperates
Algeria Kazakhstan Azerbaijan Georgia Ukraine Iraq Moldova
Own Markets (Operation through own organization/reps)
Afghanistan Vietnam Yemen Albania Libya Hong Kong Jordan Russia Turkmenistan
Kosovo Lebanon Germany France UK Belgium Netherlands Canada Uganda, Sudan,
Mauritius
Third Party Countries (Operation through distributor)
www.abdiibrahim.com.tr
Outlicensing Countries ( As of 2012)
List of Countries AİOperates
• Brazil• Venezuella• South Africa• Tunusia• Morocco• Austria• Spain• Switzerland• Hungary• Bulgaria• Croatia• GCC
100th Year
Rational Medicine Usage Campaign
Undertaking responsibility on the “Rational Medicine Use” campaign initiated by the World Health Organization for the first time in 1985 and applied by the T.R. Ministry of Health since 1992, Abdi İbrahim aims to contribute to preventing the effects of irrational medicine use on the public health and economy.
Transmitting its messages to the public with the collaboration of doctors and pharmacists via visual and printed materials in health institutions within the context of the Rational Medicine Use Campaign, Abdi İbrahim also aims to contribute to preventing the waste of resources and establishment of a healthier society by reaching a broader audience via TV ads, radio spots and magazine advertisements.
Van Gogh Alive
The Turkish pharmaceutical industry leader, Abdi İbrahim, will be celebrating its 100th anniversary with an impressive exhibit never before experienced, in which the works of one of the most famous artists in the world, Vincent Van Gogh, will be presented in a whole new format.
This exhibit, where the famous works of Vincent Van Gogh come to life at enormous scale, immersing the audience in a vibrant symphony of light, color & sound reflects Abdi İbrahim’s 100 year vision, by blending art, science and technology with an innovative approach.
